Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Half-year Financial Report – 31 December 2018
BioDiem Half-year Financial Report – 31 December 2018
March 20, 2019 •
Category
•
Author Name
Half-year Financial Report – 31 December 2018
Latest News
2022 BioDiem Annual Report
November 25, 2022
View the Annual Report
Read More
Exercise of Options
October 1, 2022
Read the announcement
Read More
